Genomics Medicine Ireland Opens Dublin Clinic for Precision Medicine Research

Genomics Medicine Ireland (GMI), the recently-acquired Irish subsidiary of WuXi NextCode, said today it has opened a research clinic in Dublin’s City Centre hub, with the goal of advancing precision medicine research and discovery...
Ambry Genetics and My Gene Counsel said they will partner to offer medical-grade testing designed to confirm results of direct-to-consumer (DTC) genetic tests

Ambry and My Gene Counsel Team Up on Tests to Confirm DTC Results, Counseling

Program designed for consumers who have taken a DTC genetic test, have a personal or family history of cancer and have unresolved questions.
Source: Huntstock/Getty Image

First AAV-Delivered Gene Therapy for Inherited Disease Approved by FDA

The FDA approval is the third for a gene therapy, but is the first approval for a treatment using adeno associated viral vector delivery
Source: efks/Getty Images

Top 15 Molecular Diagnostics M&A Deals of 2016

Molecular diagnostics accounts for only a tenth of the in vitro diagnostics (IVD) market—but most of its hopes for future revenue growth.

Exclusive: A Conversation with David Bentley, VP and Chief Scientist, Illumina

From Guy's Hospital in London and the Sanger Centre during the Human Genome Project to one of the first to join early sequencing company Solexa and its subsequent acquisition by Illumina, David Bentley has seen clinical genomics come full circle.
Myriad Genetics' myChoice HRD Plus test will be used by AstraZeneca in an exploratory analysis to identify women with advanced ovarian cancer who may benefit from maintenance treatment with a combination of AZ’s Lynparza® (olaparib) and the Genentech (Roche) cancer drug Avastin® (bevacizumab). [Source: OGphoto / Getty Images]

AZ to Use Myriad’s myChoice HRD Plus Test in Phase III Trial

Myriad Genetics will use myChoice HRD Plus to evaluate patients enrolled in an ongoing Phase III trial, in order to identify HRD cases

Lack of Diverse Ancestry Data Hinders Polygenic Risk Scores

A new study shows PRSs developed by studying Europeans do a better job at predicting disease risk for people of European ancestry than for those of other ancestries

Microsoft Launches First Microbiome Data Collaboration with Eagle Genomics

Partners will study immune disorders, antibiotic resistance by combining Microsoft's Azure cloud tech, APIs with Eagle's AI-based platform.
Killer T-lymphocyte attacking a cancer cell

10 Leading Immuno-Oncology Startups

GlaxoSmithKline (GSK)’s recently announced $4.2 billion partnership to co-develop and co-commercialize Merck KGaA, Darmstadt’s cancer immunotherapy candidate M7824 was a reminder of just how much biopharma...

We Have the Tools to Advance Precision Medicine, Why Aren’t We Using Them?

In 2013, much of the world was introduced to the burgeoning field of precision medicine when world-famous actress, Angelina Jolie, announced she had undergone...
Clinician Offering Drugs Based On DNA Profiling

FDA Sends Warning Letter to Inova Over Pharmacogenomics Test

The agency said it is unaware of data establishing that Inova’s tests helps patients or clinicians make appropriate treatment decisions for the listed drugs.

Dozens of Genetic Links to Sleep Patterns Found

The genome-wide association study found 47 links between our genetic code and the quality, quantity, and timing of how we sleep, including ten linked with sleep duration and 26 with sleep quality.

3rd European CRISPR Patent Granted to U. of California, Charpentier, U. of Vienna

The patent claims methods and compositions of using CRISPR/Cas9 to modify DNA and regulate gene activity in eukaryotic cells, including kits to carry out such work.

Myriad Genetics Expands CDx Collaboration with AstraZeneca, Merck & Co.

Myriad Genetics said today it has expanded its companion diagnostic collaboration with AstraZeneca and Merck & Co., which have agreed to use Myriad’s BRACAnalysis...

Immune System Gene Could Be Prognostic Marker for CRC

The gene, CCR4, was present in higher levels in patients with a good prognosis, even in those diagnosed with late stage colorectal cancer.
Scroll Up